The American University in Cairo (AUC) has announced a new partnership with St. George’s University (SGU) in Grenada, ...

MONTREAL, /PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

With 2025 in the history books, the African aviation sector stands at a pivotal juncture, marked by ambitious infrastructure ...

A quantitative radiomic analysis of non-contrast chest CT scans may non-invasively distinguish lung tumourlets from benign ...

Combining a host biomarker with large language model analysis improves lower respiratory tract infection diagnosis in ICU ...

Discover the top 3 undervalued Diversified Consumer Services stocks for Wednesday, January 14 based on AAII’s Stock Grades.

Travere Therapeutics, Inc., announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) ...

Alshehri, E. (2026) The Diagnostic Conundrum of Recurrent High-Grade Vaginal Intraepithelial Neoplasia (VAIN) Following ...

In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...